Regenerative Medical Technology Group Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Regenerative Medical Technology Group Inc. (RMTG) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $366.59 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-19
- Regenerative Medical Technology Group Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $104.73K, a 83.39% increase year-over-year.
- Regenerative Medical Technology Group Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $57.11K, a 17.00% increase year-over-year.
- Regenerative Medical Technology Group Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $48.81K.
- Regenerative Medical Technology Group Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$8.56K.
- Regenerative Medical Technology Group Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$209.10K, a 132.91% decline from fiscal 2024.
- Regenerative Medical Technology Group Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $635.28K.
- Regenerative Medical Technology Group Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$1.11M.
- Regenerative Medical Technology Group Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$1.33M, a 145.41% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $366.59K 10-Q · filed 2026-08-19 | |||
| 2026-03-31 | $104.73K 10-Q · filed 2026-06-09 | |||
| 2025-12-31 | -$209.10K 10-K · filed 2026-05-14 | |||
| 2025-09-30 | $19.88K 10-Q · filed 2025-11-19 | |||
| 2025-06-30 | $448.43K 10-Q · filed 2026-08-19 | |||
| 2025-03-31 | $57.11K 10-Q · filed 2026-06-09 | |||
| 2024-12-31 | $635.28K 10-K · filed 2026-05-14 | |||
| 2024-09-30 | $305.89K 10-Q · filed 2025-11-19 | |||
| 2024-06-30 | $86.55K 10-Q · filed 2025-08-19 | |||
| 2024-03-31 | $48.81K 10-Q · filed 2025-05-20 | |||
| 2023-12-31 | -$1.11M 10-K · filed 2025-04-15 | |||
| 2023-09-30 | -$501.24K 10-Q · filed 2023-11-20 | |||
| 2023-06-30 | -$420.00K 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | -$8.56K 10-Q · filed 2024-05-20 | |||
| 2022-12-31 | -$1.33M 10-K · filed 2024-04-15 | |||
| 2022-09-30 | -$1.21M 10-Q · filed 2023-11-20 | |||
| 2022-06-30 | -$1.05M 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | -$517.50K 10-Q · filed 2022-05-19 | |||
| 2021-12-31 | $2.94M 10-K · filed 2022-05-05 | |||
| 2021-09-30 | $10.69M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $10.45M 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $745.14K 10-Q · filed 2022-05-19 | |||
| 2020-12-31 | $19.16K 10-K · filed 2022-05-05 |